CMs were obtained from PC-3, DU-145, LNCaP and BPH cells, pre-treated for 48 h, with ALCAR (1 or 10 mM), in serum-free RPMI medium
Net Quantity: 30gm
Ask your clinician what fits your plan
Recent clinical results suggest that GLP-1RAs slow down the progression of PD, therefore the search for and improvement of drugs targeted by GLP-1R should be continued [63]
The discovery that NNMT expression is dramatically elevated in adipose tissue of obese humans and animal models, and that NNMT inhibition or knockdown prevents diet-induced obesity and improves metabolic health, has catalyzed intense research interest in NNMT as a therapeutic target for obesity, metabolic syndrome, and related conditions
Clinical efficacy depends on the active compound itself, not the manufacturer, so properly compounded versions deliver equivalent weight loss and metabolic benefits when dosed appropriately